Leef Brands (LEEEF) Current Assets (2024 - 2026)

Leef Brands (LEEEF) reported Current Assets of $13.7 million for Q1 2026, up 68.61% sequentially from $8.1 million in Q4 2025.

Leef Brands (LEEEF) Current Assets (2024 - 2026) Analysis & Trends

Leef Brands (LEEEF) has 3 years of Current Assets data on file, last reported at $13.7 million in Q1 2026.

  • For the quarter ending Q1 2026, Current Assets changed N/A year-over-year to $13.7 million; the trailing twelve-month figure through Mar 2026 stood at $13.7 million (changed N/A YoY), and the FY2025 full-year result was $8.1 million, down 22.23% from the prior year.
  • Current Assets improved to $13.7 million in Q1 2026, from $8.1 million in the prior quarter.
  • In the past five years, Current Assets ranged from a high of $13.7 million in Q1 2026 to a low of $8.1 million in Q4 2025.
  • A 3-year average of $10.8 million and a median of $10.5 million in 2024 frame the typical range for Current Assets.
  • Peak annual rise in Current Assets reached 22.23% in 2025, while the deepest fall reached 22.23% in 2025.
  • Tracing LEEEF's Current Assets over 3 years: stood at $10.5 million in 2024, then dropped by 22.23% to $8.1 million in 2025, then surged by 68.61% to $13.7 million in 2026.
  • Business Quant data shows LEEEF's Current Assets at $13.7 million in Q1 2026, $8.1 million in Q4 2025, and $10.5 million in Q4 2024.

Peer Comparison

# Company Market Cap Enterprise Value Gross Profit (Qtr) Current Assets (Qtr)
1 Haleon 87.22 Bn 85.35 Bn - 6.05 Bn
2 Teva Pharmaceutical Industries 39.60 Bn 35.87 Bn 1.97 Bn 13.71 Bn
3 Zoetis 31.46 Bn 29.52 Bn 1.62 Bn 6.47 Bn
4 Takeda Pharmaceutical 26.49 Bn 22.44 Bn 4.39 Bn 19.71 Bn
5 United Therapeutics 23.03 Bn 20.88 Bn 648.10 Mn 2.87 Bn
6 Universe Pharmaceuticals 23.03 Bn -10.56 Bn - 53.60 Bn
7 Viatris 20.90 Bn 19.09 Bn 1.16 Bn 10.92 Bn
8 Neurocrine Biosciences 17.50 Bn 16.19 Bn 800.70 Mn 2.44 Bn
9 Elanco Animal Health 12.33 Bn 11.91 Bn 785.00 Mn 3.58 Bn
10 Leef Brands 51.94 Mn 46.18 Mn 4.62 Mn 13.74 Mn

Historic Data

Download Data
DateValue
Mar 31, 2026 13.74 Mn
Dec 31, 2025 8.15 Mn
Dec 31, 2024 10.48 Mn